Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 3.52
(-0.28%)
CNY 3.52
(-0.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.73 Billion CNY | 1.84% |
| 2022 | 1.67 Billion CNY | -21.66% |
| 2021 | 2.13 Billion CNY | -3.17% |
| 2020 | 2.2 Billion CNY | -4.0% |
| 2019 | 2.29 Billion CNY | -6.0% |
| 2018 | 2.44 Billion CNY | 6.49% |
| 2017 | 2.29 Billion CNY | 1.1% |
| 2016 | 2.26 Billion CNY | -5.35% |
| 2015 | 2.39 Billion CNY | 18.13% |
| 2014 | 2.02 Billion CNY | 17.0% |
| 2013 | 1.73 Billion CNY | 20.89% |
| 2012 | 1.43 Billion CNY | 15.92% |
| 2011 | 1.23 Billion CNY | 44.89% |
| 2010 | 853.84 Million CNY | 11.04% |
| 2009 | 768.97 Million CNY | 6.63% |
| 2008 | 721.18 Million CNY | 12.96% |
| 2007 | 638.45 Million CNY | -1.76% |
| 2006 | 649.88 Million CNY | 42.05% |
| 2005 | 457.51 Million CNY | 24.25% |
| 2004 | 368.21 Million CNY | 83.71% |
| 2003 | 200.43 Million CNY | 59.34% |
| 2002 | 125.78 Million CNY | 61.86% |
| 2001 | 77.71 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 399.29 Million CNY | -0.71% |
| 2024 Q3 | 359.34 Million CNY | -1.46% |
| 2024 Q1 | 402.14 Million CNY | -18.23% |
| 2023 Q1 | 397.04 Million CNY | 4.29% |
| 2023 Q3 | 396.49 Million CNY | -17.19% |
| 2023 Q2 | 478.8 Million CNY | 20.59% |
| 2023 FY | 1.7 Billion CNY | 1.84% |
| 2023 Q4 | 491.81 Million CNY | 24.04% |
| 2022 Q4 | 380.69 Million CNY | -4.0% |
| 2022 Q3 | 396.56 Million CNY | -14.12% |
| 2022 Q2 | 461.78 Million CNY | 6.76% |
| 2022 FY | 1.67 Billion CNY | -21.66% |
| 2022 Q1 | 432.54 Million CNY | -8.2% |
| 2021 Q2 | 537.03 Million CNY | -3.0% |
| 2021 Q1 | 553.63 Million CNY | -4.9% |
| 2021 FY | 2.13 Billion CNY | -3.17% |
| 2021 Q4 | 471.17 Million CNY | -17.63% |
| 2021 Q3 | 572 Million CNY | 6.51% |
| 2020 Q1 | 465.97 Million CNY | -11.6% |
| 2020 Q3 | 648.59 Million CNY | 27.94% |
| 2020 Q4 | 582.17 Million CNY | -10.24% |
| 2020 FY | 2.2 Billion CNY | -4.0% |
| 2020 Q2 | 506.95 Million CNY | 8.8% |
| 2019 Q4 | 527.13 Million CNY | -22.79% |
| 2019 Q1 | 555.06 Million CNY | -12.75% |
| 2019 Q3 | 682.71 Million CNY | 28.67% |
| 2019 FY | 2.29 Billion CNY | -6.0% |
| 2019 Q2 | 530.58 Million CNY | -4.41% |
| 2018 Q1 | 577.39 Million CNY | -0.37% |
| 2018 Q4 | 636.19 Million CNY | -9.04% |
| 2018 Q2 | 528.5 Million CNY | -8.47% |
| 2018 Q3 | 699.4 Million CNY | 32.34% |
| 2018 FY | 2.44 Billion CNY | 6.49% |
| 2017 Q4 | 579.56 Million CNY | 8.11% |
| 2017 FY | 2.29 Billion CNY | 1.1% |
| 2017 Q3 | 536.06 Million CNY | -15.77% |
| 2017 Q2 | 636.42 Million CNY | 18.12% |
| 2017 Q1 | 538.8 Million CNY | -4.94% |
| 2016 Q4 | 566.77 Million CNY | -3.75% |
| 2016 FY | 2.26 Billion CNY | -5.35% |
| 2016 Q1 | 487.39 Million CNY | -23.36% |
| 2016 Q3 | 588.83 Million CNY | -5.64% |
| 2016 Q2 | 624.01 Million CNY | 28.03% |
| 2015 Q1 | 458.2 Million CNY | -33.35% |
| 2015 FY | 2.39 Billion CNY | 18.13% |
| 2015 Q4 | 635.98 Million CNY | 7.2% |
| 2015 Q3 | 593.28 Million CNY | -16.1% |
| 2015 Q2 | 707.11 Million CNY | 54.32% |
| 2014 Q4 | 687.46 Million CNY | 30.74% |
| 2014 Q1 | 430.18 Million CNY | -29.89% |
| 2014 FY | 2.02 Billion CNY | 17.0% |
| 2014 Q2 | 384.61 Million CNY | -10.59% |
| 2014 Q3 | 525.81 Million CNY | 36.71% |
| 2013 FY | 1.73 Billion CNY | 20.89% |
| 2013 Q4 | 613.58 Million CNY | 37.46% |
| 2013 Q3 | 446.35 Million CNY | 39.82% |
| 2013 Q1 | 354.22 Million CNY | -27.91% |
| 2013 Q2 | 319.24 Million CNY | -9.88% |
| 2012 Q3 | 315.75 Million CNY | -4.57% |
| 2012 FY | 1.43 Billion CNY | 15.92% |
| 2012 Q1 | 295.84 Million CNY | -19.98% |
| 2012 Q2 | 330.86 Million CNY | 11.84% |
| 2012 Q4 | 491.33 Million CNY | 55.61% |
| 2011 Q1 | 272.78 Million CNY | 0.7% |
| 2011 Q3 | 301.02 Million CNY | 2.52% |
| 2011 Q4 | 369.7 Million CNY | 22.82% |
| 2011 Q2 | 293.61 Million CNY | 7.64% |
| 2011 FY | 1.23 Billion CNY | 44.89% |
| 2010 Q4 | 270.9 Million CNY | 21.79% |
| 2010 Q1 | 171.83 Million CNY | -25.69% |
| 2010 FY | 853.84 Million CNY | 11.04% |
| 2010 Q2 | 188.66 Million CNY | 9.8% |
| 2010 Q3 | 222.44 Million CNY | 17.9% |
| 2009 Q4 | 231.23 Million CNY | 19.0% |
| 2009 Q3 | 194.3 Million CNY | 11.72% |
| 2009 Q2 | 173.92 Million CNY | 2.61% |
| 2009 Q1 | 169.5 Million CNY | -31.17% |
| 2009 FY | 768.97 Million CNY | 6.63% |
| 2008 Q4 | 246.27 Million CNY | 40.71% |
| 2008 FY | 721.18 Million CNY | 12.96% |
| 2008 Q1 | 157.58 Million CNY | -27.47% |
| 2008 Q2 | 142.29 Million CNY | -9.7% |
| 2008 Q3 | 175.02 Million CNY | 23.0% |
| 2007 Q1 | 121.51 Million CNY | -63.93% |
| 2007 Q2 | 154.03 Million CNY | 26.76% |
| 2007 FY | 638.45 Million CNY | -1.76% |
| 2007 Q4 | 217.27 Million CNY | 49.21% |
| 2007 Q3 | 145.62 Million CNY | -5.46% |
| 2006 Q2 | 104.83 Million CNY | 15.36% |
| 2006 Q1 | 90.87 Million CNY | -41.41% |
| 2006 Q4 | 336.91 Million CNY | 187.34% |
| 2006 Q3 | 117.25 Million CNY | 11.85% |
| 2006 FY | 649.88 Million CNY | 42.05% |
| 2005 Q4 | 155.09 Million CNY | 40.34% |
| 2005 FY | 457.51 Million CNY | 24.25% |
| 2005 Q1 | 83.11 Million CNY | -46.49% |
| 2005 Q2 | 108.78 Million CNY | 30.89% |
| 2005 Q3 | 110.51 Million CNY | 1.59% |
| 2004 Q1 | 68.71 Million CNY | 0.0% |
| 2004 Q3 | 72.1 Million CNY | 0.04% |
| 2004 Q2 | 72.07 Million CNY | 4.9% |
| 2004 FY | 368.21 Million CNY | 83.71% |
| 2004 Q4 | 155.32 Million CNY | 115.41% |
| 2003 FY | 200.43 Million CNY | 59.34% |
| 2002 FY | 125.78 Million CNY | 61.86% |
| 2001 FY | 77.71 Million CNY | 0.0% |